Tenuecyclamides A−D, Cyclic Hexapeptides from the Cyanobacterium Nostoc spongiaeforme var. tenue
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Four modified cyclic hexapeptides, tenuecyclamides A-D (1-4), were isolated along with the known antibiotic, borophycin (5), from the methanol extract of Nostoc spongiaeforme var. tenue (TAU strain IL-184-6). The planar structure of tenuecyclamides A-D (1-4) was determined by homonuclear and inverse-heteronuclear 2D-NMR techniques as well as by high-resolution mass spectrometry measurements. The absolute configuration of the asymmetric centers was studied by Marfey's method for HPLC. The stereochemistry of the asymmetric centers in tenuecyclamides A and B (1 and 2) could not be fully determined, while that of tenuecyclamides C and D (3 and 4) was unambiguously determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These include cyto toxins Cryptophycin I from Nostoc sp. GSV224 (Golakoti et al., 1995; Singh et al., 2011) and Borophcin from Nostoc spongiaeforme var. Tenue (Banker and Carmeli, 1998).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Banker and Carmeli, 1998
Citations
Cites
Antibiotics in laboratory medicine
Balows, A. (1986) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(86)90044-1 · Cited by 337
Todorova, A. K., Juettner, F., Linden, A., Pluess, T., & von Philipsborn, W. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00129a032 · Cited by 147
Ogino, J., Moore, R. E., Patterson, G. M. L., & Smith, C. D. (1996) · Journal of Natural Products · doi:10.1021/np960178s · Cited by 140
Prinsep, M. R., Moore, R. E., Levine, I. A., & Patterson, G. M. L. (1992) · Journal of Natural Products · doi:10.1021/np50079a022 · Cited by 121
Foster, M. P., Concepción, G. P., Caraan, G. B., & Ireland, C. M. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00050a063 · Cited by 102
Cycloxazoline: A cytotoxic cyclic hexapeptide from the ascidian lissoclinum bistratum.
Hambley, T. W., Hawkins, C. J., Lavin, M. F., van den Brenk, A. L., & Watters, D. J. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)88146-1 · Cited by 89
Raocyclamides A and B, Novel Cyclic Hexapeptides Isolated from the Cyanobacterium Oscillatoria raoi
Admi, V., Afek, U., & Carmeli, S. (1996) · Journal of Natural Products · doi:10.1021/np960115+ · Cited by 57
Self-citationKinetics and thermodynamics of cis-trans isomerization of captopril and related compounds
Mariappan, S. V. S., & Rabenstein, D. L. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00050a064 · Cited by 20
Research works printed but not linked: 8
- Patterson G. M. L., 1994, J. Appl. Phycol., 6, 157
- Namikoshi M., 1996, J. Indus. Microbiol., 17, 384
- Degan B. M., 1989, J. Med. Chem., 32, 1359
- Ojika M., 1995, Tetrahedron Lett., 36, 5058
- Desikachary T., 1956, Cyanophyta, 391
- Ikegami S., 1979, Agric. Biol. Chem., 43, 161
- Marfey P., 1984, Carlsberg Res. Commun., 49, 596
- Stainer R. Y., 1971, Bacterial. Rev., 35, 205
Cited by
Marine cyanobacteria—a prolific source of natural products
Burja, A. M., Banaigs, B., Abou-Mansour, E., Grant Burgess, J., & Wright, P. C. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00931-0 · Cited by 841
Construction of sulfur-containing moieties in the total synthesis of natural products
Wang, N., Saidhareddy, P., & Jiang, X. (2020) · Natural Product Reports · doi:10.1039/c8np00093j · Cited by 750
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555
“tenue [94], attributed potent cytotoxicity against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines [95].”
BackgroundApplications of cyanobacteria in biotechnology
Abed, R. M. M., Dobretsov, S., & Sudesh, K. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03918.x · Cited by 528
Biosynthesis of polyketides by trans-AT polyketide synthases
Helfrich, E. J. N., & Piel, J. (2016) · Natural Product Reports · doi:10.1039/c5np00125k · Cited by 478
Health applications of bioactive compounds from marine microalgae
de Jesus Raposo, M. F., de Morais, R. M. S. C., & de Morais, A. M. M. B. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.08.002 · Cited by 410
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment: Miniperspective
Waghray, D., & Zhang, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01457 · Cited by 400
Singh, R., Parihar, P., Singh, M., Bajguz, A., Kumar, J., Singh, S., Singh, V. P., & Prasad, S. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00515 · Cited by 398
Anticancer Drugs from Marine Flora: An Overview
Sithranga Boopathy, N., & Kathiresan, K. (2010) · Journal of Oncology · doi:10.1155/2010/214186 · Cited by 394
“tenue Borophycin Cytotoxicity against human epidermoid carcinoma (LoVo) and human colorectal adenocarcinoma activity [48]”
BackgroundGrams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Natural Products from Cyanobacteria: Focus on Beneficial Activities
Demay, J., Bernard, C., Reinhardt, A., & Marie, B. (2019) · Marine Drugs · doi:10.3390/md17060320 · Cited by 324
Exploitation of marine algae: biogenic compounds for potential antifouling applications
Bhadury, P., & Wright, P. (2004) · Planta · doi:10.1007/s00425-004-1307-5 · Cited by 327
“…2002; Dobretsov and Qian 2002; Steinberg and de Nys 2002; Hellio et al. 2001; Burja et al. 2001; Steinberg et al. 2001; Vairappan et al. 2001; Abarzua et al. 1999; Banker and Carmeli 1998; Clare 1996; Padmakumar et al. 1993; Mizukoshi et al. 1992; Bernard and Pesando 1989; Wahidulia et al. 1987).”
BackgroundA global assembly line for cyanobactins
Donia, M. S., Ravel, J., & Schmidt, E. W. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.84 · Cited by 279
Cyanobactins—ribosomal cyclic peptides produced by cyanobacteria
Sivonen, K., Leikoski, N., Fewer, D. P., & Jokela, J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2482-x · Cited by 275
“Tenuecyclamides are hexapeptides containing two thiazoles and an oxazole (Banker and Carmeli 1998, Table 2).”
BackgroundDembitsky, V. M., Al Quntar, A. A. A., & Srebnik, M. (2011) · Chemical Reviews · doi:10.1021/cr100093b · Cited by 241
YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function
Burkhart, B. J., Schwalen, C. J., Mann, G., Naismith, J. H., & Mitchell, D. A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00623 · Cited by 213
Microalgae in modern cancer therapy: current knowledge
Abd El-Hack, M. E., Abdelnour, S., Alagawany, M., Abdo, M., Sakr, M. A., Khafaga, A. F., Mahgoub, S. A., Elnesr, S. S., & Gebriel, M. G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.069 · Cited by 206
Pharmaceutical applications of cyanobacteria—A review
Vijayakumar, S., & Menakha, M. (2015) · Journal of Acute Medicine · doi:10.1016/j.jacme.2015.02.004 · Cited by 205
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I.-S., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2018.11.008 · Cited by 181
The chemical ecology of cyanobacteria
Leão, P. N., Engene, N., Antunes, A., Gerwick, W. H., & Vasconcelos, V. (2012) · Natural Product Reports · doi:10.1039/c2np00075j · Cited by 174
LuxS and Autoinducer-2: Their Contribution to Quorum Sensing and Metabolism in Bacteria
Winzer, K., Hardie, K. R., & Williams, P. (2003) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(03)53009-x · Cited by 169
Desriac, F., Defer, D., Bourgougnon, N., Brillet, B., Le Chevalier, P., & Fleury, Y. (2010) · Marine Drugs · doi:10.3390/md8041153 · Cited by 167
Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria
Swain, S. S., Paidesetty, S. K., & Padhy, R. N. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.030 · Cited by 163
Gogineni, V., & Hamann, M. T. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.08.014 · Cited by 163
Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer
Wali, A. F., Majid, S., Rasool, S., Shehada, S. B., Abdulkareem, S. K., Firdous, A., Beigh, S., Shakeel, S., Mushtaq, S., Akbar, I., et al. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.04.013 · Cited by 158
“Again in later stage, Banker and Carmeli stated that, this novel bioactive compound can be derived from both terrestrial strain of Streptomyces antibioticus as well as from marine strain S. griseus ( Banker et al., 1998).”
Microalgae as a source of bioactive molecules – experience from cyanophyte research
Skulberg, O. M. (2000) · Journal of Applied Phycology · doi:10.1023/a:1008140403621 · Cited by 189
Natural occurrence of boron-containing compounds in plants, algae and microorganisms
Dembitsky, V. M., Smoum, R., Quntar, A. A. A. A., Ali, H. A., Pergament, I., & Srebnik, M. (2002) · Plant Science · doi:10.1016/s0168-9452(02)00174-7 · Cited by 139
Portmann, C., Blom, J. F., Gademann, K., & Jüttner, F. (2008) · Journal of Natural Products · doi:10.1021/np800118g · Cited by 154
Biochemical and pharmacological investigations of selected cyanobacteria
Mundt, S., Kreitlow, S., Nowotny, A., & Effmert, U. (2001) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00045 · Cited by 150
Portmann, C., Blom, J. F., Kaiser, M., Brun, R., Jüttner, F., & Gademann, K. (2008) · Journal of Natural Products · doi:10.1021/np800409z · Cited by 159
Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Chlipala, G. E., Mo, S., & Orjala, J. (2011) · Current Drug Targets · doi:10.2174/138945011798109455 · Cited by 152
Heteroaryl Rings in Peptide Macrocycles
Smolyar, I. V., Yudin, A. K., & Nenajdenko, V. G. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00789 · Cited by 136
Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides
Rojas, V., Rivas, L., Cárdenas, C., & Guzmán, F. (2020) · Molecules · doi:10.3390/molecules25245804 · Cited by 124
Ziemert, N., Ishida, K., Quillardet, P., Bouchier, C., Hertweck, C., de Marsac, N. T., & Dittmann, E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02392-07 · Cited by 120
Boronated tartrolon antibiotic produced by symbiotic cellulose-degrading bacteria in shipworm gills
Elshahawi, S. I., Silva, A. E. T., Hanora, A., Han, A., Flores, M. S., Vizzoni, V. F., Schrago, C. G., Soares, C. A. G., Concepción, G. P., Distel, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213892110 · Cited by 130
“Boromycin Present Streptomyces antibioticus Antibacterial (58, 59) (terrestrial) Anti-HIV Aplasmomycin Present Streptomyces griseus Antiplasmodium (27, 60) (marine) Antibacterial Borophycin Present Cyanobacteria Antibacterial (61, 62) Nostoc linckia Cytotoxic Nostoc spongiaeforme var.”
BackgroundBiologically active compounds of semi-metals
Řezanka, T., & Sigler, K. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.018 · Cited by 140
Marine Cyanobacteria and Microalgae Metabolites—A Rich Source of Potential Anticancer Drugs
Mondal, A., Bose, S., Banerjee, S., Patra, J. K., Malik, J., Mandal, S. K., Kilpatrick, K. L., Das, G., Kerry, R. G., Fimognari, C., et al. (2020) · Marine Drugs · doi:10.3390/md18090476 · Cited by 126
Nostocyclamide M: a cyanobacterial cyclic peptide with allelopathic activity from Nostoc 31
Jüttner, F., Todorova, A. K., Walch, N., & von Philipsborn, W. (2001) · Phytochemistry · doi:10.1016/s0031-9422(00)00470-2 · Cited by 112
Factors affecting antimicrobial activity of Synechococcus leopoliensis
Noaman, N., Fattah, A., Khaleafa, M., & Zaky, S. (2004) · Microbiological Research · doi:10.1016/j.micres.2004.09.001 · Cited by 129
Apratoxin H and Apratoxin A Sulfoxide from the Red Sea Cyanobacterium Moorea producens
Thornburg, C. C., Cowley, E. S., Sikorska, J., Shaala, L. A., Ishmael, J. E., Youssef, D. T. A., & McPhail, K. L. (2013) · Journal of Natural Products · doi:10.1021/np4004992 · Cited by 104
Dutta, D., Debnath, M., Müller, D., Paul, R., Das, T., Bessi, I., Schwalbe, H., & Dash, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky385 · Cited by 96
Cyanobacteria and microalgae in supporting human habitation on Mars
Mapstone, L. J., Leite, M. N., Purton, S., Crawford, I. A., & Dartnell, L. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107946 · Cited by 92
“Tenue (Banker and Carmeli, 1998).”
Metabolites produced by nitrogen-fixingNostoc species
Dembitsky, V. M., & Řezanka, T. (2005) · Folia Microbiologica · doi:10.1007/bf02931419 · Cited by 102
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2019.05.001 · Cited by 106
A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites
Nagarajan, M., Veerabadhran, M., & Sundararaman, M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1717 · Cited by 101
Cyanobactins from Cyanobacteria: Current Genetic and Chemical State of Knowledge
Martins, J., & Vasconcelos, V. M. (2015) · Marine Drugs · doi:10.3390/md13116910 · Cited by 109
Biomedicinals from the phytosymbionts of marine invertebrates: A molecular approach
Dunlap, W. C., Battershill, C. N., Liptrot, C. H., Cobb, R. E., Bourne, D. G., Jaspars, M., Long, P. F., & Newman, D. J. (2007) · Methods · doi:10.1016/j.ymeth.2007.03.001 · Cited by 96
Cyanobacteria: Applications in Biotechnology
Kumar, J., Singh, D., Tyagi, M. B., & Kumar, A. (2019) · Cyanobacteria · doi:10.1016/b978-0-12-814667-5.00016-7 · Cited by 72
Leucamide A: A New Cytotoxic Heptapeptide from the Australian Sponge Leucetta microraphis
Kehraus, S., König, G. M., Wright, A. D., & Wörheide, G. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo020058r · Cited by 89
You, S., & Kelly, J. W. (2004) · Organic Letters · doi:10.1021/ol049439c · Cited by 82
Bajpai, V. K., Shukla, S., Kang, S., Hwang, S. K., Song, X., Huh, Y. S., & Han, Y. (2018) · Marine Drugs · doi:10.3390/md16060179 · Cited by 86
Biogenetic Diversity of Cyanobacterial Metabolites
Wagoner, R. M. V., Drummond, A. K., & Wright, J. L. C. (2007) · Advances in applied microbiology · doi:10.1016/s0065-2164(06)61004-6 · Cited by 90
Microcyclamide, a Cytotoxic Cyclic Hexapeptide from the Cyanobacterium Microcystis aeruginosa
Ishida, K., Nakagawa, H., & Murakami, M. (2000) · Journal of Natural Products · doi:10.1021/np000159p · Cited by 95
Pluotno, A., & Carmeli, S. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.11.016 · Cited by 76
Self-citationAsthana, R. K., Deepali, Tripathi, M. K., Srivastava, A., Singh, A. P., Singh, S. P., Nath, G., Srivastava, R., & Srivastava, B. S. (2008) · Journal of Applied Phycology · doi:10.1007/s10811-008-9328-2 · Cited by 82
“D (Banker and Carmeli 1998) from N. spongiaeforme, noscomin (Jaki et al. 1999a) and comnostin A–”
BackgroundGenome mining for natural product biosynthetic gene clusters in the Subsection V cyanobacteria
Micallef, M. L., D’Agostino, P. M., Sharma, D., Viswanathan, R., & Moffitt, M. C. (2015) · BMC Genomics · doi:10.1186/s12864-015-1855-z · Cited by 87
Qamar, H., Hussain, K., Soni, A., Khan, A., Hussain, T., & Chénais, B. (2021) · Molecules · doi:10.3390/molecules26010247 · Cited by 75
Leikoski, N., Fewer, D. P., & Sivonen, K. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02134-08 · Cited by 74
Modified peptides from a water bloom of the cyanobacterium Nostoc sp.
Ploutno, A., & Carmeli, S. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)01326-1 · Cited by 76
Self-citationEmerging biopharmaceuticals from bioactive peptides derived from marine organisms
Anjum, K., Abbas, S. Q., Akhter, N., Shagufta, B. I., Shah, S. A. A., & Hassan, S. S. U. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12925 · Cited by 64
Dahiya, R., Dahiya, S., Fuloria, N. K., Kumar, S., Mourya, R., Chennupati, S. V., Jankie, S., Gautam, H., Singh, S. K., Karan, S. K., et al. (2020) · Marine Drugs · doi:10.3390/md18060329 · Cited by 75
Didmolamide A and B, Two New Cyclic Hexapeptides from the Marine Ascidian Didemnum molle
Rudi, A., Chill, L., Aknin, M., & Kashman, Y. (2003) · Journal of Natural Products · doi:10.1021/np020531w · Cited by 59
Current Status and Future Strategies to Increase Secondary Metabolite Production from Cyanobacteria
Jeong, Y., Cho, S.-H., Lee, H., Choi, H.-K., Kim, D.-M., Lee, C.-G., Cho, S., & Cho, B.-K. (2020) · Microorganisms · doi:10.3390/microorganisms8121849 · Cited by 57
“Nucleoside Toyocamycin Antifungal Tolypothrix [72] Nucleoside Tubercidin Antifungal Tolypothrix [73]”
BackgroundBeltrán, J. M. G., Arizcún, M., & Chaves-Pozo, E. (2023) · Marine Drugs · doi:10.3390/md21050290 · Cited by 57
Biomedical Applications of Biosynthesized Gold Nanoparticles from Cyanobacteria: an Overview
Mandhata, C. P., Sahoo, C. R., & Padhy, R. N. (2022) · Biological Trace Element Research · doi:10.1007/s12011-021-03078-2 · Cited by 64
Biotechnological exploitation of cyanobacteria and microalgae for bioactive compounds
Singh, S. K., Kaur, R., Bansal, A., Kapur, S., & Sundaram, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64323-0.00008-4 · Cited by 66
Naturally Occurring Oxazole-Containing Peptides
Mhlongo, J. T., Brasil, E. M., de la Torre, B. G., & Alberício, F. (2020) · Marine Drugs · doi:10.3390/md18040203 · Cited by 50
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Demay, J., Halary, S., Knittel-Obrecht, A., Villa, P., Duval, C., Hamlaoui, S., Roussel, T., Yéprémian, C., Reinhardt, A., Bernard, C., et al. (2020) · Biomolecules · doi:10.3390/biom11010028 · Cited by 54
Balgacyclamides, Antiplasmodial Heterocyclic Peptides from Microcystis aeruguinosa EAWAG 251
Portmann, C., Sieber, S., Wirthensohn, S., Blom, J. F., Silva, L. D., Baudat, E., Kaiser, M., Brun, R., & Gademann, K. (2014) · Journal of Natural Products · doi:10.1021/np400814w · Cited by 52
Oryzamides A–E, Cyclodepsipeptides from the Sponge-Derived Fungus Nigrospora oryzae PF18
Ding, L., Yuan, W., Liao, X., Han, B., Wang, S., Li, Z., Xu, S., Zhang, W. Y., & Lin, H. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00349 · Cited by 49
The total synthesis of bistratamides F–I
You, S., & Kelly, J. W. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.10.024 · Cited by 47
Total synthesis of didmolamides A and B
You, S., & Kelly, J. W. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.02.097 · Cited by 47
Nawaz, T., Gu, L., Fahad, S., Saud, S., Jiang, Z.-Y., Hassan, S., Harrison, M. T., Liu, K., Khan, M. A., Liu, H., et al. (2023) · Food and Energy Security · doi:10.1002/fes3.495 · Cited by 49
Ribosomal synthesis of backbone macrocyclic peptides
Katoh, T., Goto, Y., Reza, M. S., & Suga, H. (2011) · Chemical Communications · doi:10.1039/c1cc12647d · Cited by 43
Nagarajan, M., Veerabadhran, M., & Sundararaman, M. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2833 · Cited by 44
“Cyanobacteria are the prolific producers of thiazolecontaining cyclopeptides, viz., microcyclamides, raocyclamides, tenuecyclamides, nostocyclamide, etc. (Admi et al., 1996; Banker and Carmeli, 1998; Ishida et al., 2000b; Raveh et al., 2010; Zafrir-Ilan and Carmeli, 2010b).”
BackgroundSchizopeptin 791, a New Anabeanopeptin-like Cyclic Peptide from the Cyanobacterium Schizothrix sp.
Reshef, V., & Carmeli, S. (2002) · Journal of Natural Products · doi:10.1021/np020039c · Cited by 38
Self-citationThe Role of Trace Elements in Living Organisms
Gumienna‐Kontecka, E., Rowińska‐Żyrek, M., & Łuczkowski, M. (2018) · Wiley eBooks · doi:10.1002/9781119133780.ch9 · Cited by 45
Raveh, A., Moshe, S., Evron, Z., Flescher, E., & Carmeli, S. (2010) · Tetrahedron · doi:10.1016/j.tet.2010.02.008 · Cited by 37
Self-citationWu, Z., Li, S., Nam, S., Liu, Z., & Zhang, C. (2013) · Journal of Natural Products · doi:10.1021/np400009a · Cited by 39
The use of cyanobacterial metabolites as natural medical and biotechnological tools: review article
Saad, M. H., El‐Fakharany, E. M., Salem, M. S., & Sidkey, N. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1838948 · Cited by 46
“The most common cyanobacterial source of borophycin is Nostoc spongiaeforme var. tenue (Banker & Carmeli, 1998; Davidson, 1995; C. Gupta et al., 2012 ).”
BackgroundCyanobactins – Ubiquitous Cyanobacterial Ribosomal Peptide Metabolites
Donia, M. S., & Schmidt, E. W. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00664-x · Cited by 37
You, S., Deechongkit, S., & Kelly, J. W. (2004) · Organic Letters · doi:10.1021/ol049020m · Cited by 33
Biologically Active Compounds Of Semi-Metals
Řezanka, T., & Sigler, K. (2008) · Studies in natural products chemistry · doi:10.1016/s1572-5995(08)80018-x · Cited by 40
Fujii, K., Yahashi, Y., Nakano, T., Imanishi, S. Y., Baldia, S. F., & Harada, K. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00748-2 · Cited by 30
Two new microcyclamides from a water bloom of the cyanobacterium Microcystis sp.
Zafrir‐Ilan, E., & Carmeli, S. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.10.051 · Cited by 29
Self-citationAyswaria, R., Vijayan, J., & Nathan, V. K. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3779 · Cited by 36
Aeruginazole A, a Novel Thiazole-Containing Cyclopeptide from the Cyanobacterium Microcystis sp.
Raveh, A., & Carmeli, S. (2010) · Organic Letters · doi:10.1021/ol1014015 · Cited by 32
Self-citationInsights of Antioxidants as Molecules for Drug Discovery
Baunthiyal, M., Singh, V., & Dwivedi, S. (2017) · International Journal of Pharmacology · doi:10.3923/ijp.2017.874.889 · Cited by 34
Origin of Chemical Diversity in Prochloron-Tunicate Symbiosis
Lin, Z., Torres, J. P., Tianero, M. D. B., Kwan, J. C., & Schmidt, E. W. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00860-16 · Cited by 30
Phycochemistry and bioactivity of cyanobacterial secondary metabolites
Srivastava, R., Prajapati, R., Kanda, T., Yadav, S., Singh, N., Yadav, S., Mishra, R., & Atri, N. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07911-2 · Cited by 30
An Overview of Bioactive 1,3-Oxazole-Containing Alkaloids from Marine Organisms
Chen, J., Lv, S.-Y., Liu, J., Yu, Y., Wang, H., & Zhang, H. (2021) · Pharmaceuticals · doi:10.3390/ph14121274 · Cited by 27
Erickson, K. L., Gustafson, K. R., Milanowski, D. J., Pannell, L. K., Klose, J. R., & Boyd, M. R. (2003) · Tetrahedron · doi:10.1016/j.tet.2003.10.060 · Cited by 24
Recent progression of cyanobacteria and their pharmaceutical utility: an update
Bishoyi, A. K., Sahoo, C. R., & Padhy, R. N. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2062051 · Cited by 30
“Tenuecyclamides Cytotoxic exhibited and antimicrobial activity against B. subtilis and S. aureus 6mm; concentration of 100 and 10 mg/mL. Banker & Carmeli, 1998 Tolypothrix byssoidea 65.”
BackgroundInfluentialUrda, C., Fernández, R., Rodrı́guez, J., Pérez, M., Jiménez, C., & Cuevas, C. (2017) · Marine Drugs · doi:10.3390/md15070209 · Cited by 22
Chapter 8 - Marine Resource: A Promising Future for Anticancer Drugs
Gupta, A., Pandotra, P., Sharma, R., Kushwaha, M., & Gupta, S. (2013) · Studies in natural products chemistry · doi:10.1016/b978-0-444-59603-1.00008-4 · Cited by 28
Cyanobacteria-based microbial cell factories for production of industrial products
Hamouda, R. A., & El‐Naggar, N. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821477-0.00007-6 · Cited by 28
Cyanobacterial natural products as antimicrobial agents.
Pandey, V. D. (2015) · International Journal of Current Microbiology and Applied Sciences · Cited by 25
Synthesis of Bistratamide H Using a New Fluorous Protecting Group
Nakamura, Y., & Takeuchi, S. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200640053 · Cited by 18
Cyanobacteria as a biofuel source: advances and applications
Sitther, V., Tabatabai, B., Fathabad, S. G., Gichuki, S. M., Chen, H., & Arumanayagam, A. C. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819311-2.00018-8 · Cited by 26
Metadata
- Authors
- Banker, R., & Carmeli, S.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Carmeli, Shmuel
- ORCID
- Carmeli, Shmuel
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-08-15
- Volume
- 61
- Issue
- 10
- Pages
- 1248-1251
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2015171291
- Cited by
- 152
- References
- 8
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 3 · 2015: 7 · 2014: 2 · 2013: 9 · 2012: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Natural Products (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- cyclic hexapeptide, cyanobacterial natural products, antibiotics, structure elucidation, absolute configuration, stereochemistry, modified amino acids
- MeSH terms
- Cyanobacteria, Animals, Anti-Bacterial Agents, Magnetic Resonance Spectroscopy, Oligopeptides, Peptides, Cyclic, Sea Urchins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.